Related Experiment Video
Updated: Mar 2, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Decreased left atrial myocardial strain in patients with suboptimal blood pressure control
Xiao-Jing Chen1, Chen Chen1, Yu-Jia Liang1
1a Department of Cardiology, West China Hospital , Sichuan University , Chengdu , China.
Insights
Suboptimal blood pressure control in hypertensive patients further impairs left atrial (LA) function. Achieving optimal blood pressure may be a simplified treatment target to preserve cardiac health.
Area of Science:
- Cardiology
- Hypertension Research
- Cardiac Physiology
Background:
- Suboptimal blood pressure (BP) control is prevalent in patients on antihypertensive therapy.
- The impact of uncontrolled BP on left atrial (LA) function is not well understood.
Purpose of the Study:
- To investigate the relationship between suboptimal BP control and LA myocardial function in medicated hypertensive patients.
- To assess if suboptimal BP control is an independent risk factor for LA impairment.
Main Methods:
- Enrolled 279 hypertensive patients (medicated) and 85 controls.
- Defined optimal BP as systolic <140 mmHg and diastolic <90 mmHg; suboptimal BP as otherwise.
- Assessed LA myocardial function using systolic (SSa), early diastolic (SEa), and late diastolic (SAa) LA strains via 2DSTE.
Main Results:
- Hypertensive groups showed higher BP, thicker interventricular septum, larger LA volume index, and enhanced active atrial emptying fraction than controls.
- Hypertensive patients had reduced SSa, SEa, and SAa compared to controls (p < 0.001).
- Suboptimal BP control (HT2 group) was associated with further impaired SEa (p = 0.002) and identified as an independent risk factor for abnormal SEa (OR, 2.957; p = 0.001).
Conclusions:
- Suboptimal BP control is linked to further reduction in LA myocardial function.
- Suboptimal BP control may serve as a composite risk factor and a simplified treatment target.
- Future studies should evaluate the prognostic value of LA strain in patients unable to reach BP targets.
Background:
Suboptimal blood pressure (BP) control is commonly observed in patients receiving antihypertensive agents, but the relationship between uncontrolled BP and left atrial (LA) impairment remains unknown.
Methods:
This study enrolled 279 hypertensive patients who had been medicated, as well as 85 matched normal controls. The BP of systolic <140 mmHg and diastolic<90 mmHg was defined as optimal (HT1 group, n=146), otherwise as suboptimal BP control (HT2 group, n = 133). LA myocardial function was assessed by the systolic (SSa), early diastolic (SEa), and late diastolic (SAa) LA strains.
Results:
Both the HT1 group and HT2 group had higher BP reading, thicker interventricular septum, larger LA volume index, and enhanced active atrial emptying fraction than the control group (all <0.05). When compared with normal subjects, hypertensive patients displayed obvious reduction in the SSa (50.0 ± 10.9 vs. 35.9 ± 8.0%), SEa (30.1 ± 7.7 vs. 18.5 ± 7.1%) and SAa (19.9 ± 6.4 vs. 17.8 ± 4.2%) (all p < 0.001). In addition to a further impaired SEa found in the HT2 group than in the HT1 group (17.2 ± 5.3 vs. 19.8 ± 8.3%, p = 0.002), the treated BP of >140/90 mmHg appeared an independent risk factor associated with the abnormal SEa (odds ratio, 2.957; interval of confidence, 1.614-5.415; p = 0.001).
Conclusions:
Suboptimal BP control status in hypertensive patients is related to a further reduction of LA myocardial function assessed by the novel 2DSTI free strain, and suboptimal BP might be regarded as a composite risk factor and therefore a simplified treatment target. However, the prognostic value of LA free strain in patients with inability to achieve the BP target needs to be evaluated in future prospective studies.
More Related Videos
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Aortic Regurgitation III: Medical Management
Measurement of Blood Pressure
Heart Failure Drugs: β-Blockers
Cardiomyopathy III: Hypertrophic Cardiomyopathy

